Purchase Order 36C24720P1259

This federal contract award is for the Provant Therapy System, a proprietary medical device developed by Regenesis Biomedical Inc. The $7,203.90 firm fixed-price contract was awarded by the Department of Veterans Affairs (VA) through VA Integrated Service Network 17. The contract is for the supply and rental of the Provant Therapy System, which is indicated for the palliative treatment of post-operative pain and edema. The contract was awarded as a purchase order and is not associated with any...

This federal contract award is for the provision of the Provant Therapy System by Regenesis Biomedical Inc. to the Department of Veterans Affairs (VA). The contract, valued at $7,145.55, is a firm-fixed-price purchase order awarded on August 19, 2011 with a completion date of September 18, 2011. The Provant Therapy System is a non-invasive regenerative medicine product indicated for the palliative treatment of post-operative pain and edema. Regenesis Biomedical, a for-profit manufacturer, has...

This federal contract award was issued by the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a private medical technology company, for the provision of the Provant Therapy System and related rental services. The $4,820.98 firm fixed-price purchase order contract was awarded on April 21, 2011, with a completion date of May 21, 2011. The contract was issued against Regenesis Biomedical's existing GSA Schedule 65-II-A for medical equipment and supplies, and did not utilize any...

This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a privately held medical technology company. The $4,820.98 contract is for the Provant Therapy System, a noninvasive regenerative medicine product developed and patented by Regenesis Biomedical. The Provant Therapy System is indicated for the palliative treatment of post-operative pain and edema. The contract has an ultimate completion date of March 16, 2011. Regenesis...

This federal contract award is for the provision of the Provant Therapy System, a patented medical device developed by Regenesis Biomedical Inc. The $4,820.98 firm fixed-price purchase order was awarded by the Department of Veterans Affairs (VA) to Regenesis Biomedical, the prime contractor, under a GSA Schedule 65-II-A contract for medical equipment and supplies. The contract is for the delivery of the Provant Therapy System device and related rental services to a VA healthcare facility in...

This is a $3,645.14 firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc. for the Provant Therapy System, a noninvasive regenerative medicine product. The contract is not set-aside and was awarded under Regenesis Biomedical's existing GSA Schedule 65-II-A contract for medical equipment and supplies. The Provant Therapy System is indicated for palliative treatment of post-operative pain and edema, and Regenesis Biomedical appears to be the...

This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a medical technology company, for the Provant Therapy System. The contract, valued at $4,992.40, is for the provision of the Provant Therapy System, a non-invasive regenerative medicine product indicated for the palliative treatment of post-operative pain and edema. The contract is not associated with a set-aside program and appears to be part of Regenesis...

This federal contract award is for the provision of the Provant Therapy System by Regenesis Biomedical Inc. to the Department of Veterans Affairs (VA). The Provant Therapy System is a noninvasive regenerative medicine product indicated for the palliative treatment of post-operative pain and edema. The contract, valued at $10,067.09, is a firm fixed-price purchase order with no set-aside designation. Regenesis Biomedical Inc. acts as the prime contractor, providing the Provant Therapy System...

This federal contract award is for the Department of Veterans Affairs (VA) to procure the Provant Therapy System and associated rental services from Regenesis Biomedical Inc. The $3,645.14 firm fixed-price purchase order was issued under Regenesis Biomedical's GSA Schedule 65-II-A contract for medical equipment and supplies. The Provant Therapy System is Regenesis Biomedical's patented non-invasive regenerative medicine product, indicated for palliative treatment of post-operative pain and...

This federal contract award is for the procurement of the Provant Therapy System by the Department of Veterans Affairs (VA). The prime contractor is Regenesis Biomedical Inc., a privately held medical technology company that develops and markets the Provant Therapy System, a non-invasive regenerative medicine product. The contract, valued at $4,820.98, is a firm fixed-price purchase order for the Provant Therapy System. The award was made through the VA's Federal Supply Schedule 65-II-A for...